$AUNA

AUNA S.A.

Insider trades

No enriched coverage for $AUNA in the last 7 days.

No SEC Form 4 filings for $AUNA in the last 30 days.

See all $AUNA insider activity →
Low

Why Auna’s (AUNA) Analyst Upside Depends on Latin American Healthcare Platform Execution

Auna S.A. (NYSE:AUNA) is covered by seven analysts. The average target implies ~32.6% upside, but JPMorgan on May 26 kept a Hold rating and cut its price target to $5 from $6. S&P Global shows a Buy consensus with an average target of $6.99. Fitch affirmed a B+ rating on May 22, citing material leverage; the outlook depends on execution across Latin American healthcare services.

AUNA sentiment & insider activity

Recent AUNA coverage spans insider activity and financial news.

What's driving AUNA

  • Street view is mixed: consensus still implies upside, but JPMorgan’s PT cut and Fitch’s leverage flag keep risk elevated.

    yahoo.com · Jul 7, 2026

  • Insider buying may modestly support sentiment, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

  • Insider buying can modestly support near-term sentiment, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

  • Insider open-market buying can modestly support sentiment, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

  • Insider open-market buying may be read as mild bullish signal, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 2, 2026

alphai scores every news story that mentions AUNA with an AI model for sentiment and relevance, and aggregates insider trades from AUNA S.A.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $AUNA

Score
$AUNALow

Why Auna’s (AUNA) Analyst Upside Depends on Latin American Healthcare Platform Execution

Auna S.A. (NYSE:AUNA) is covered by seven analysts. The average target implies ~32.6% upside, but JPMorgan on May 26 kept a Hold rating and cut its price target to $5 from $6. S&P Global shows a Buy consensus with an average target of $6.99. Fitch affirmed a B+ rating on May 22, citing material leverage; the outlook depends on execution across Latin American healthcare services.

$MSMed

Morgan Stanley lowers Auna SA stock price target to $10 from $11.50

Morgan Stanley has reduced its price target for Auna SA (NYSE:AUNA) to $10.00 from $11.50, while maintaining an Overweight rating. Despite the lowered target, the firm sees over 100% upside potential from the current price, citing Auna's growth in Mexico, strong operating cash flow for debt reduction, and a strategy of penetrating low-priced healthcare markets in Peru and Mexico. Auna recently reported strong Q3 2025 EPS of $1.10, significantly exceeding analyst expectations, though the stock still saw a decline.

Related tickers